Here are six quick points:
1. The company announced a 1-for-20 reverse split.
2. The reverse stock split will become effective on July 7.
3. Once the reverse stock split is effective, every 20 shares of common stock outstanding will be converted into one share of common stock.
4. As a result of the split, the number of outstanding shares will be reduced from 54 million to 2 million.
5. BioRestorative Therapies’ common stock will begin trading on a split-adjusted basis under the temporary ticker symbol “BRTXD.” The temporary ticker symbol will remain in effect for 20 days, after which it will revert back to “BRTX.”
6. The company focuses on developing therapeutic products and medical therapies using cell and tissue protocols.
More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
